MyFinsight
Home
Blog
About
Back
Income Statement
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)
source: myfinsight.com
Net gain and
comprehensive gain
-$4,347K
Gain from operations
-$4,224K
Total other expense
-$123K
Total operating
expenses
$4,224K
Interest expense
$123K
General and
administrative
$2,975K
Research and development
$1,249K
Back